The promise and challenge of anti-HIV cellular immunity.

The promise and challenge of anti-HIV cellular immunity.

PURPOSE OF REVIEW: We discuss recent studies giving insight into the promise of cell-mediated immunity for prophylactic HIV vaccine strategies, and challenges to be overcome for this approach to succeed. RECENT FINDINGS: Advances in understanding of events in very early HIV infection and their impo...

Bibliografske podrobnosti
Main Authors:	Borrow, P, Turnbull, E
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

The immune response to human immunodeficiency virus type 1 (HIV-1)
od: Turnbull, E, et al.
Izdano: (2005)

Anti-HIV-1 nanotherapeutics : promises and challenges for the future
od: Mahajan, Supriya D., et al.
Izdano: (2013)

Anti-HIV-1 nanotherapeutics: promises and challenges for the future
od: Mahajan SD, et al.
Izdano: (2012-10-01)

Anti-HIV cellular immunity: recent advances towards vaccine design.
od: Goulder, P, et al.
Izdano: (1999)

Innate immunity in acute HIV-1 infection
od: Borrow, P
Izdano: (2011)

Innate immunity in acute HIV-1 infection.
od: Borrow, P
Izdano: (2011)

Cellular immune responses to HIV.
od: Mcmichael, A, et al.
Izdano: (2001)

Innate immune responses in primary HIV-1 infection.
od: Borrow, P, et al.
Izdano: (2008)

Immune Checkpoint in Glioblastoma: Promising and Challenging
od: Jing Huang, et al.
Izdano: (2017-05-01)

In silico models for cellular and molecular immunology: successes, promises and challenges.
od: Chakraborty, A, et al.
Izdano: (2003)

Innate immunity against HIV: a priority target for HIV prevention research.
od: Borrow, P, et al.
Izdano: (2010)

Innate immunity against HIV: a priority target for HIV prevention research
od: Vyakarnam Annapurna, et al.
Izdano: (2010-10-01)

Gene therapy for hearing loss: challenges and the promise of cellular plasticity and epigenetic modulation
od: Samprita Das, et al.
Izdano: (2024-12-01)

Humoral and Cellular Immune Pressures May Converge at the Base of the V3 Loop During Rwandan Subtype A HIV-1 Infection
od: Murphy, M, et al.
Izdano: (2011)

Radiation for awakening the dormant immune system, a promising challenge to explore
od: Luis eDe La Cruz-Merino, et al.
Izdano: (2014-03-01)

Tweaking Innate Immunity: The Promise of Innate Immunologicals as Anti-Infectives
od: Kenneth L Rosenthal
Izdano: (2006-01-01)

Role of cellular immunity in protection against HIV infection.
od: Rowland-Jones, S, et al.
Izdano: (1997)

Manipulating NK cellular therapy from cancer to invasive fungal infection: promises and challenges
od: Bernice Ling Zhi Oh, et al.
Izdano: (2023-01-01)

The Role of T Cell Immunity in the Control of HIV Infection
od: Goonetilleke, N, et al.
Izdano: (2010)

Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
od: Asmae Squalli Houssaini, et al.
Izdano: (2024-06-01)

On drug therapy for an HIV infection age model with cellular and immune delays
od: Nicoleta E. Tarfulea
Izdano: (2024-08-01)

The dynamics of the cellular immune response to HIV infection: implications for vaccination.
od: Mcmichael, A, et al.
Izdano: (2000)

Immune checkpoint modulation enhances HIV-1 antibody induction
od: Bradley, T, et al.
Izdano: (2020)

The Promise of the Anti-Idiotype Concept
od: Thomas eKieber-Emmons, et al.
Izdano: (2012-12-01)

The immune response during acute HIV-1 infection: clues for vaccine development.
od: Mcmichael, A, et al.
Izdano: (2010)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
od: Peter G. Hendrickson, et al.
Izdano: (2020-01-01)

The importance of cellular immune response to HIV: implications for antibody production and vaccine design
od: Brenna, E, et al.
Izdano: (2021)

Gamma/delta T cells as cellular vehicles for anti-tumor immunity
od: Chelsia Qiuxia Wang, et al.
Izdano: (2024-01-01)

Natural Killer Cell-Based Cancer Immunotherapies: From Immune Evasion to Promising Targeted Cellular Therapies
od: Erhard Hofer, et al.
Izdano: (2017-07-01)

Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics
od: Matthew R. Gardner
Izdano: (2020-04-01)

FUNCTIONAL CHARACTERIZATION OF CELLULAR FACTORS OF THE INNATE IMMUNE PROTECTION IN THE DYNAMICS OF HIV-INFECTION
od: L. A. Kotieva, et al.
Izdano: (2013-09-01)

Constitutionalizing FIFA: Promises and Challenges
od: Bodo P. Bützler, et al.
Izdano: (2020-06-01)

ICAMs are dispensable for influenza clearance and anti-viral humoral and cellular immunity
od: Stav Kozlovski, et al.
Izdano: (2023-02-01)

Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges
od: Lynda Coughlan, et al.
Izdano: (2015-04-01)

Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients
od: Liting Yan, et al.
Izdano: (2023-05-01)

New and promising anti-bacterials: Can this promise be sustained?
od: Sai Saran, et al.
Izdano: (2020-01-01)

Is Aducanumab for LMICs? Promises and Challenges
od: Illangage P. C. Gunawardena, et al.
Izdano: (2021-11-01)

Promises and challenges in pharmacoepigenetics
od: Delaney A. Smith, et al.
Izdano: (2023-01-01)

Sustainability: The Challenges and the Promise
od: George J. Mitchell
Izdano: (2012-02-01)

Humoral and cellular immune response of mice challenged with Yersinia pestis antigenic preparations
od: Elida A. Leal, et al.
Izdano: (2017-11-01)